Accumulating evidence showed that the m6A modification components in β-cells might contribute to the pathophysiology of T2D before its onset, while the mRNA hypomethylation characteristics of genes in the insulin/IGF1-PDX1 pathway in T2D islets might be novel targets for the early diagnosis of T2D. Here, IGF1 is linked to type 2 diabetes mellitus.